Skip to main content
Top
Published in: Breast Cancer Research 1/2002

01-07-2002 | Meeting abstract

Sloane Project: a prospective audit of screen detected ductal carcinoma in situ

Authors: A Evans, H Bishop, K Chambers, H Dobson, IO Ellis, A Hanby, O Kearins, G Lawrence, SR Lakhani, JC Macartney, AJ Maxwell, SE Pinder, ME Wheaton, MG Wallis

Published in: Breast Cancer Research | Special Issue 1/2002

Login to get access

Excerpt

One thousand nine hundred and fifty-three non-invasive breast cancers were diagnosed by the National Health Service Breast Screening Programme (NHSBSP) in women aged 50–64 during the period 1999–2000. Prior to the introduction of screening only 295 cases of ductal carcinoma in situ (DCIS) were recorded in England and Wales in women in the same age band. The reason for this is that the trademark characteristic of microcalcification in the majority of DCIS cases is easily visualised radiologically on a mammogram. Consequently, with the introduction of breast screening, the incidence of this type of cancer has been increasing rapidly, and DCIS now accounts for approximately 20% of all cancers detected by the NHSBSP. …
Metadata
Title
Sloane Project: a prospective audit of screen detected ductal carcinoma in situ
Authors
A Evans
H Bishop
K Chambers
H Dobson
IO Ellis
A Hanby
O Kearins
G Lawrence
SR Lakhani
JC Macartney
AJ Maxwell
SE Pinder
ME Wheaton
MG Wallis
Publication date
01-07-2002
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue Special Issue 1/2002
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr474

Other articles of this Special Issue 1/2002

Breast Cancer Research 1/2002 Go to the issue

Meeting abstract

Reconstruction

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine